In recent months, reports of rising HIV infections in Malaysia have once again made national headlines. The data paints a ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

Progress towards The Lancet Commission on Global Surgery's 2030 targets has been too slow and too patchy, particularly in low ...

Psilocybin shows promise for extending lifespan and slowing aging by preserving telomeres, new studies reveal.

The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorse ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.

Integrating HIV and sexual health care is essential for improving outcomes, but global stigma, funding cuts—especially the defunding of USAID—and structural barriers like limited access and political ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

(NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today ...

Find Global Vaccination Latest News, Videos & Pictures on Global Vaccination and see latest updates, news, information from NDTV.COM. Explore more on Global Vaccination.

Find Global Vaccines Latest News, Videos & Pictures on Global Vaccines and see latest updates, news, information from NDTV.COM. Explore more on Global Vaccines.